Condition
Papillary Renal Cell Carcinoma (Prcc) clinical trials and research
Research outlook What's coming for Kidney cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Papillary Renal Cell Carcinoma (Prcc) clinical trials that are recruiting, at sites in 2 countries (most in United States (2), China (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Evaluating SIM0505 for advanced solid tumors
This study is testing a new treatment called SIM0505 to see if it is safe and effective for adults with advanced solid tumors that haven't responded to other therapies.
-
Combining Palbociclib and Sasanlimab for Advanced Kidney Cancer Treatment
This study is testing if a combination of two drugs, palbociclib and sasanlimab, can help people with advanced kidney cancer feel better and improve their treatment outcomes.
Related topics
Quick answers
How many Papillary Renal Cell Carcinoma (Prcc) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.